Some Molecular and Clinical Aspects of Genetic Predisposition to Malignant Melanoma and Tumours of Various Site of Origin

Table 4 Frequencies of CDKN2A variant alleles in breast cancer patients

Age	Number tested	Mutation positive	Prevalence [%]	Odds ratio	p
≥ 50 years
20–30	66	8	12.10	3.8	0.0002
31–40	582	24	4.10	1.2	0.46
41–50	2670	136	5.10	1.5	0.003
total	3318	168	5.10	1.5	0.002
>50 years
51+	891	40	4.50	1.3	0.17

ISSN: 1897-4287